Approval from FDA and European Commission for Sirturo (bedaquiline) as part of combination therapy in adult and pediatric patients with pulmonary tuberculosis due to mycobacterium tuberculosis – Johnson & Johnson
Johnson & Johnson announced that the FDA has issued traditional approval for Sirturo (bedaquiline) as part of combination therapy in adult and pediatric patients (5 years and older… read more.
